Technical information
Manufacturer
Laboratoire PROCTER & GAMBLE PHARMACEUTICALS FRANCE
Presentation
INTRINSA 300 µg/24 h, dispositif transdermique Boîte de 8 - Code CIP : 376 704-4
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
433VtA8z3yrCmu9A